Microbot Stock Based Compensation To Revenue from 2010 to 2025
| MBOT Stock | USD 1.52 0.04 2.56% |
Stock Based Compensation To Revenue | First Reported 2010-12-31 | Previous Quarter 41.72 | Current Value 39.63 | Quarterly Volatility 379.09985961 |
Check Microbot Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Microbot Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 90.6 K, Interest Expense of 158.5 M or Total Revenue of 0.0, as well as many indicators such as Price To Sales Ratio of 302, Dividend Yield of 58.41 or PTB Ratio of 4.49. Microbot financial statements analysis is a perfect complement when working with Microbot Medical Valuation or Volatility modules.
Microbot | Stock Based Compensation To Revenue |
Latest Microbot Medical's Stock Based Compensation To Revenue Growth Pattern
Below is the plot of the Stock Based Compensation To Revenue of Microbot Medical over the last few years. It is a metric that compares the total value of stock-based compensation granted by a company to its total revenue, indicating how much of the revenue is used to compensate employees with stock options or awards. Microbot Medical's Stock Based Compensation To Revenue historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Microbot Medical's overall financial position and show how it may be relating to other accounts over time.
| Stock Based Compensation To Revenue | 10 Years Trend |
|
Stock Based Compensation To Revenue |
| Timeline |
Microbot Stock Based Compensation To Revenue Regression Statistics
| Arithmetic Mean | 122.48 | |
| Geometric Mean | 23.15 | |
| Coefficient Of Variation | 309.51 | |
| Mean Deviation | 177.55 | |
| Median | 36.28 | |
| Standard Deviation | 379.10 | |
| Sample Variance | 143,717 | |
| Range | 1.5K | |
| R-Value | (0.39) | |
| Mean Square Error | 130,557 | |
| R-Squared | 0.15 | |
| Significance | 0.14 | |
| Slope | (31.06) | |
| Total Sum of Squares | 2.2M |
Microbot Stock Based Compensation To Revenue History
About Microbot Medical Financial Statements
Microbot Medical shareholders use historical fundamental indicators, such as Stock Based Compensation To Revenue, to determine how well the company is positioned to perform in the future. Although Microbot Medical investors may analyze each financial statement separately, they are all interrelated. The changes in Microbot Medical's assets and liabilities, for example, are also reflected in the revenues and expenses on on Microbot Medical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Stock Based Compensation To Revenue | 41.72 | 39.63 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Microbot Stock Analysis
When running Microbot Medical's price analysis, check to measure Microbot Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Microbot Medical is operating at the current time. Most of Microbot Medical's value examination focuses on studying past and present price action to predict the probability of Microbot Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Microbot Medical's price. Additionally, you may evaluate how the addition of Microbot Medical to your portfolios can decrease your overall portfolio volatility.